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Abstract 
 
Atherosclerosis in 64-year-old women with diabetes mellitus and impaired glucose tolerance 
The incidence of obesity and type-2 diabetes (t2D) is rising around the world.  T2D is accompanied 
by an increased risk of macrovascular, atherosclerotic diseases. The timing of the disease process 
and exact mechanism underlying the association between diabetes and atherosclerotic disease are 
not known. High-resolution B-mode ultrasound is a non-invasive technique to measure very early 
atherosclerotic disease as the intima-media thickness (IMT) and to assess occurrence, size and 
echogenicity of atherosclerotic plaques in superficial arteries such as the carotid arteries. 
Remodelling, i.e a change in vascular diameter in response to atherosclerosis may also be 
examined. 
The overall aim of this thesis was to examine the occurrence of early atherosclerosis in t2D and 
impaired glucose tolerance (IGT). Our hypothesis was that there is a gradual enlargement of IMT 
and an increased occurrence of plaques, especially echolucent plaques, with worsening glucose 
tolerance, accompanied by a remodelling that might be visible already in subjects with IGT.  
In order to summarise current knowledge a systematic reviews were made in order to identify 
cross-sectional studies using the ultrasound method. The differences between IMT in t2D or IGT 
and control subjects were calculated. Meta-analysis using random-effects model was used to 
calculate summary measures. In a cross-sectional study, the entire cohort of 64 years old women in 
Göteborg were invited to take part in a screening examination. Of these, 2595 participated and 
underwent anthropometric measurements and an oral glucose tolerance test (OGTT) that was 
repeated within two weeks. Ultrasound examinations were made in a cohort of women with known 
(n=99) and new diabetes (n=106), IGT (n=205) and NGT (n=188).  
In the systematic review of 23 studies we found that t2D was associated with an 0.13 mm increase 
in IMT compared to controls. There was a considerable heterogeneity between the studies that 
complicated the interpretation of the meta-analysis. This difference can be interpreted as if the 
diabetic patients were ten years older than the control group and that they had an elevated risk for 
stroke and myocardial infarction. In patients with IGT, the increase in IMT was about 25% of that 
observed in diabetes.  
The screening examination showed that 10% of the women had diabetes of whom half were newly 
detected. Without repeated OGTTs 37% of the new diabetes would have been missed. The women 
with t2D had larger IMT and plaqueareas compared to women in IGT and NGT groups. The 
plaques were most frequenty echolucent. In the IGT group, no increase in atherosclerosis was 
observed, but the result was within the confidenceinterval of the meta-analysis, indicating that IGT 
is associated with a small increase in IMT in the CCA (0.03mm). Carotid vascular remodelling 
with enlargement in IMT and lumen diameter had however occurred already in the women with 
new t2D. This remodelling process was seen only in women with atherosclerotic plaques and was 
not associated to t2D per se.  
In conclusion, already in screening detected diabetes sub-clinical atherosclerosis with IMT 
enlargement and occurrence of plaque with vascular remodelling are observed, indicating that a 
powerful intervention must be initiated in such cases. 
Keywords; systematic review, atherosclerosis, type-2 diabetes, IMT, vascular remodelling, IGT. 
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Abbreviations 
ADA American Diabetes Association   
BMI Body Mass Index 
CCA Common Carotid Artery 
CI Confidence Interval 
CAD Coronary Artery Disease 
CVD Cardiovascular disease  
ECG Electrocardiogram 
DM Diabetes Mellitus 
FBG Fasting Blood Glucose 
FH+ Family history of diabetes in any of the parents 
FH- No family history of diabetes in any of the parents  
GAD Glutamic Acid Decarboxylase 
HDL High Density Lipoprotein 
IFG Impaired Fasting Glucose 
IGT Impaired Glucose Tolerance 
IMT Intima Media Thickness 
LDL Low Density Lipoprotein 
NGT Normal Glucose Tolerance 
NGTm NGT, matched 
NGTr NGT, random 
OGTT Oral Glucose Tolerance Test  
SD Standard Deviation 
TG Triglyceride 
T2D Type 2 Diabetes 
WHR Waist Hip Ratio  
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Introduction 
Recently UN declared that diabetes mellitus is a chronic, debilitating and costly 
disease associated with severe complications, which poses severe risks for 
families, Member States, and the entire world (General Assembly – 61st session – 
Agenda 113). Obesity and physical inactivity are the main underlying causes. 
Diabetes is a strong risk factor for development of atherosclerosis and 
cardiovascular diseases [Meigs 2002, Wei 1998]. Even when adjusted for 
conventional risk factors, diabetic individuals still exhibit a two- to fourfold 
increased relative risk in comparison to non-diabetic subjects [Stamler 1993]. 
This risk is even higher among diabetic women compared to non-diabetic women 
[Niskanen 1998]. It is a huge challenge to prevent this threat to public health and 
to better understand the underlying disease mechanism. 
Onset and diagnosis of diabetes mellitus  
Diabetes mellitus has several causes, ranging from autoimmune disease processes 
(type-1) to a combination of insulin resistance and pancreatic beta-cell 
insufficiency as a result of different mechanisms (type-2). There is also an 
overlap between type-1 and type-2 diabetes [Groop 1998, Groop 1988, Tuomi 
1999]. Environmental and life style factors are important, especially obesity and 
a sedentary life style, that explain the steady raise in the incidence of type 2 
diabetes. The current concept is that there is a gradual development of glucose 
intolerance with insulin resistance, and deteriorating beta-cell function leading to 
impaired glucose tolerance and finally diabetes[Stumvoll 2005]. The diagnosis is 
arbitrary as shown by the changing cut-off levels for definition of diabetes [WHO 
1999]. It should be kept in mind that the diabetic complications that have been 
used in the attempt to decide the blood glucose level that is associated with 
increased risk are related to micro- and not macrovascular diseases [Engelgau 
1997, McCance 1997]. OGTT is the golden standard in diagnosing diabetes 
mellitus. According to the latest guidelines, fasting glucose values have been 
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harmonised with OGTT values [ADA 2006, Engelgau 1997, Finch 1990, WHO 
1999]. However, the OGTT is characterised by a high degree of intraindividual 
variability. [Feskens 1991, McDonald 1965, Riccardi 1985]. 
Type -2 diabetes is the most common form of diabetes and a worldwide epidemic 
increase is expected during the first quarter of the 21th century [Amos 1997, King 
1998]. This increase is, however not so apparent in the Scandinavian countries 
[Drivsholm 2001, Eliasson 2002, Jansson 2007, Vilbergsson 1997] even if 
overweight is becoming more common [C Berg 2005].  
Figure 1 demonstrates the prevalence of diabetes mellitus in European countries 
[Ryden 2007]. As seen in the figure there is a steep rise in diabetes prevalence 
after the age of 50 in men and after the age of 60 in women. For each decade the 
prevalence increases and this is most explicit in women. Other data indicate that 
the onset of type-2 diabetes occurs several years before clinical diagnosis [Harris 
1992].  
 
Figure 1. Age-and gender-specific prevalence of diabetes (DM) in 13 European 
population-based cohort included in the DECODE study. DMF = DM determined by 
FPG≥7.0 mmol/l and 2 h plasma glucose < 11.1 mmol/l. DMP = DM determined by 2 h 
plasma glucose ≥ 11.1 mmol/l. (L.Rydén 2007) Reprinted with permission from 
European Heart Journal. 
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Impaired glucose tolerance (IGT) was defined in 1979 in USA by the National 
Diabetes Data Group as a state of disturbed glucose metabolism. IGT is viewed 
as a transitional stage in the development from normal glucose tolerance to type-
2 diabetes. This concept that IGT is a road to diabetes is supported by results 
from two studies showing that in subjects with IGT, life style treatment with 
weight reduction and increased physical exercise prevents the transition to 
diabetes [Knowler 2002, Lindstrom 2003, Lindstrom 2006, Tuomilehto 2001]. 
Impaired glucose tolerance (IGT) often coexists with a cluster of metabolic 
abnormalities such as; hypertension, central obesity, dyslipidemia, insulin 
resistance [Kylin 1923, Reaven 1988]. It is known that IGT is associated with a 
risk of future cardiovascular disease (CVD) [Coutinho 1999, Fuller 1980, Meigs 
2002]. It is not clear if high “non-diabetic” glucose levels are independently 
related to atherosclerosis [Bonora 1999] Data indicate, however that IGT is a risk 
factor for CVD even when IGT is not followed by the subsequent development 
of diabetes [Qiao 2003].  
The prevalence of IGT varies between different populations, just as the 
prevalence of diabetes. In a large population-based study in Sweden the 
prevalence of IGT among women at the age of 60 was 11% [Lindahl 1999]. 
(Against this background it is of interest to know the prevalence of IGT 
and diabetes in high risk groups such as women in late middle-age using 
repeated OGTT as the most sensitive diagnostic method.) 
Atherosclerosis and diabetes  
Atherosclerosis is an insidious process with specific predilection sites in the 
arterial tree. Atherosclerosis is found in young adults and increases steadily in 
parallel with aging [Dahl-Jorgensen 2005, Zieske 2002]. Manifest atherosclerotic 
diseases typically start in middle age and increase steeply in parallel with aging 
as shown in the Oxvasc-study [Rothwell 2005]. As previously mentioned 
diabetes is associated with an increased cardiovascular risk, also when 
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conventional risk factors have been taken into account. Many patients already 
have atherosclerotic disease when the diagnosis of diabetes is made [Uusitupa 
1985]. 
Mechanisms involved in atherosclerosis 
The mechanisms of atherogenesis in atherosclerotic disease are not fully known. 
The most popular hypothesis explaining the atherosclerotic process is the 
response to retention hypothesis [Camejo 1998, Carew 1984, Falcone 1984, 
Schwenke 1989]. The infiltration and retention of LDL-cholesterol in the arterial 
intima initiate an inflammatory process in the arterial wall where the 
modification of LDL through oxidation or other mechanisms take place 
[Leitinger 2003, Skalen 2002]. This process includes the activation of endothelial 
cells preferentially at sites of hemodynamic strain in the artery wall [Leitinger 
2003] [Nakashima 1998]. A critical step in the development of atherosclerosis is 
taken when cytokine and cell adhesion molecules, produced in the inflamed 
intima, induce the monocytes to enter the plaque and differentiate into 
macrophages [Smith 1995]. The macrophages is thereafter further transformed to 
cholesterol-laden foam cells [Haberland 1984].  
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Figure 2. LDL infiltrates the artery and is retained in the intima, particularly at sites of 
hemodynamic strain. The modified LDL particles are taken up by macrophages, which 
evolve into foam cells. (G Hansson.2005) Reprinted with permission from N Eng J Med. 
 
Accumulation of macrophages, migration and proliferation of smooth-muscle 
cells and formation of fibrous tissue lead to further enlargement and restructuring 
of the lesion. The lesion becomes covered by a fibrous cap that overlies a core of 
lipid and necrotic tissue. An advanced, complicated lesion is created [Ross 1999]. 
The hallmark of atherosclerosis is the fibrous plaque. Such plaque increase by 
age and among 60 year old subjects more than half have plaques in the carotide 
arteries [Joakimsen 1999]. In the further process some lesions develop into 
vulnerable plaques which in general are characterised by large lipid pool, a thin 
overlying cap and an abundance of inflammatory cells in the shoulder regions of 
the plaque [Mann 1996].  
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Figure 3. The formation of the vulnerable plaque with the lipid-core and the thin fibrous 
cap. The fibrous cap covers a mixture of leukocytes, lipids and debris, which may form a 
necrotic core.(Ross, R 1999) Reprinted with permission from N Eng J Med. 
 
Some of these plaques rupture or have proportions that lead to thrombosis,   
resulting in end organ damage[Fuster 1990, Rothwell 2005]. Plaque vulnerability 
and plaque rupture are also mechanisms related to symptomatic plaques in the 
carotid arteries (Rothwell, 2005). 
In the coronary circulation other mechanisms than plaque rupture are involved in 
acute coronary syndrome.  
Ultrasound diagnosis of atherosclerosis in the carotid arteries 
Non-invasive ultrasound techniques have been developed, enabling studies of 
atherosclerosis during the long clinically silent phase. B-mode ultrasound is a 
method that allows quantification and qualification of atherosclerosis in terms of 
intima-media thickness (IMT) and the occurrence and characteristics of 
atherosclerotic plaques [Gronholdt 1997, Schmidt 1999]. The lumen-intima and 
media-adventitia echoes in carotid ultrasound images were first identified by 
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Pignoli and co-workers [Pignoli 1986]. Our group also showed that the far wall 
IMT and lumen diameter could be measured in a valid way [Wendelhag 1991]. 
Several large epidemiological studies have demonstrated an association between 
carotid artery IMT and CVD risk factors in both men and women [Bonithon-
Kopp 1991, Mathiesen 2001, Mitsuhashi 2002, O'Leary 1999]. Studies have also 
showed a relationship between carotid IMT and the angiographic presence of 
coronary artery disease (CAD) [Hulthe 1997, Wofford 1991] and the number of 
coronary vessels with lesions [Wofford 1991]. In addition, prospective studies 
have demonstrated a relationship between carotid IMT and future CAD [Bots 
1997, Chambless 1997, Hodis 1998, O'Leary 1999] 
The number of plaques and the degree of stenosis also predicts risk for CVD 
events [Hollander 2002, Mathiesen 2001]. Plaque occurrence in the carotid 
arteries has shown a positive correlation with coronary atherosclerosis [Hulthe 
1997] and stroke [Hollander 2002]. In subjects with stabile angina, plaques are 
more common in patients with subsequent CVD-death or myocardial infarction 
compared to event-free subjects [Held 2001]. Studies have shown that age, 
systolic blood pressure, cholesterol and smoking are associated with plaques 
[Ebrahim 1999].  
However, most atherosclerotic plaques never lead to clinical disease and the 
development of vulnerable plaque with plaque rupture. There is a need to identify 
vulnerable plaques and the ultrasound technique can be used for this purpose. 
Carotid plaques can be classified into those with low-level echoes (echolucent 
plaques) and those with medium and high-level echoes (echogenic plaques) 
[Gray-Weale 1988, Reilly 1983]. In the carotid artery the echolucent plaques 
seem to be lipid-rich, whereas echogenic plaques have a high content of fibrous 
tissue and calcifications as assessed by ultrasound related to histology [El-
Barghouty 1996, Gronholdt 1997].  
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Figure 4. Plaque echogenicity; 1) Dominantly echolucent with thin echogenic cap. 2) 
Substantially echolucent with small areas of echogenicity. 3) Dominantly echogenic 
lesions with small areas of echolucency. 4) Uniformly echogenic lesions. 
 
Echolucent plaques are associated with cardio-vascular events, silent coronary 
ischemia [Belcaro 1993, Geroulakos 1993] and also with ischemic 
cerebrovascular events [Honda 2004, Mathiesen 2001, Schmidt 2003]. Also the 
degree of echolucency in non-stenotic plaques is related to the future risk of 
CVD[Honda 2004]. 
(More knowledge is needed to better understand the involved mechanisms behind 
the development of vulnerable plaques and to identify the risk factors correctly. 
There is also a need for better imaging and information regarding the prevalence 
of echolucent plaques in t2D.) 
Diabetes, IGT and atherosclerosis. 
Atherosclerotic disease is a major complication of diabetes mellitus. A number of 
known risk factors for coronary disease such as hypertension and abnormal lipids 
are also more common in diabetics than the general population. However, no 
more than 25% of the excess coronary atherosclerotic from diabetes can be 
2 
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attributed to these known risk factors [Keaney 2000]. The mechanism behind the 
relation between diabetes and atherosclerosis is not fully known. Oxidative 
stress, through the production of reactive oxygen species (ROS) has been 
proposed as the root cause underlying insulin resistance, type 2 diabetes and 
vascular complications [Ceriello 2004]. Apart from inflammation and diabetic 
dyslipidemia [Haffner 2003], the impaired glucose metabolism and “advanced 
glycation end products” (AGE) [Bansilal 2007, Brownlee 1992, Cipollone 2003] 
might contribute to the atherosclerotic process.  
There are many studies indicating that type-2 diabetes mellitus (t2D) is 
associated with thicker intima-media in the carotid artery [Folsom 1994, 
Wagenknecht 1998]. Some studies have, on the other hand, not showed any 
significant difference between t2D and controls [el-Barghouti 1997, Tuomilehto 
1998]. 
Studies examining whether IGT is associated with increased carotid IMT show 
inconsistent results [Ishizaka 2003, Temelkova-Kurktschiev 2000, Wagenknecht 
1998]. However, all these studies were based on one single OGTT, and it is 
known that glucose tolerance is normal at a second OGTT in half of the cases 
[Riccardi 1985]. 
 (Hence, a more strict diagnosis of IGT using repeated OGTT may show more 
consistent association with IMT. Taken together it is unclear when the 
atherosclerotic process starts in relation to the level of glucose intolerance.) 
Remodelling 
Remodelling is a process when the artery geometry changes as a response to the 
atherosclerotic process [Pasterkamp 2002, Ward 2000]. In histological sections 
of coronary arteries Glagov et. al., demonstrated that coronary arteries enlarge in 
response to the development of atherosclerotic plaques [Glagov 1987]. 
According to the analyses of Glagov et al the compensatory remodelling process 
maintained or even enlarged luminal dimensions during early atherosclerosis. 
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These investigators also reported that the capacity for compensatory enlargement 
diminished as plaques reached a cross-sectional area stenosis of ~ 40 % and 
plaque growth beyond this point resulted in a reduction of luminal area.(Figure 5) 
[Glagov 1987].  
 
 
Figure 5. In early atherosclerosis a compensatory remodelling process is maintaining or 
even enlarging the lumen dimension. (Glagov et al, N Eng J Med 1987)   
 
It has been suggested to take lumen diameter and remodelling into account when 
examining the importance of IMT as a surrogate marker of atherosclerotic 
disease [Bots 2005]. One previous study has indicated that remodelling occurs 
among patients with known diabetes but the relation to plaques is unknown 
[Henry 2004]. Artery size is also related to other factors. Male sex, height, 
weight and blood pressure are positively associated with carotid artery lumen 
diameter [Bonithon-Kopp 1996]. An increased IMT may also be a non-
atherosclerotic response to increased stress in order to keep the wall tension 
normal [Bots 2005].  
(There is a lack of knowledge regarding the onset of atherosclerosis assessed as 
increase in IMT, plaque occurrence and remodelling in relation to the gradual 
deterioration of glucose tolerance, leading to diabetes.) 
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Aims of the study 
The main aim of this thesis was to examine the occurrence of early 
atherosclerosis in type 2 diabetes (t2D) and impaired glucose tolerance (IGT). 
The specific aims were: 
 
I. To perform a systematic review and a meta-analysis of the literature in 
order to clarify whether t2D and IGT are associated with increased 
carotid artery IMT, and to relate differences in IMT to clinical correlates 
such as age and risk for myocardial infarction and stroke. (Paper I) 
 
II. To describe the prevalence of diabetes mellitus and IGT in a cohort of 
64-year-old women in Gothenburg, Sweden and to examine the 
variability and practical use of the OGTT in the screening for IGT and 
diabetes. (Paper  II) 
 
III. To investigate the occurrence of echolucent plaques in diabetic patients; 
to examine if carotid artery remodelling in women is present already at 
the diagnosis of new t2D, and if it is similar to that in known t2D, and to 
investigate if non-atherosclerotic remodelling may occur in t2D. (Paper 
III) 
 
IV. To examine if IGT, as diagnosed by double OGTT, is associated with 
sub clinical carotid atherosclerosis assessed as IMT and occurrence of 
echolucent plaques. A post-hoc aim was to clarify if carotid IMT is 
thicker in groups of IGT compared to groups of NGT by performing an 
up-dated meta-analysis, adjusted for differences in age. (Paper IV) 
  
Materials and Methods 
20 
Materials and Methods 
Paper I  
Study design of the systematic review 
Inclusion criteria 
Inclusion criteria were 1) cross-sectional studies of patients with type 2 diabetes 
mellitus or impaired glucose tolerance (IGT), and controls; 2) use of the 
ultrasound method to examine the carotid artery IMT. Type 2 diabetes was 
defined by the authors concerned, and IGT was based on the WHO 
definition[WHO 1999].  Both epidemiological, cross-sectional studies based on 
random population samples and case-control studies were included. If a study 
was reported in more than one publication we could use data from other 
publications to obtain necessary information, but only one report was included.  
Search strategy 
MEDLINE, EMBASE, and Cochrane were the primary sources of identification 
of included studies. We started our searches with the keywords “diabetes”, 
“impaired glucose tolerance”, “atherosclerosis” and “intima-media”. The 
searches spanned the previous 20 years. The references in the identified or 
related articles were manually reviewed in the search for other published studies. 
Articles in languages other than English were accepted. Personal contacts with 
researchers in the field were used to identify unpublished studies. 
Data extraction 
A data abstract form was created and two of the authors (GB, BF) independently 
extracted the requested information. The tabulated data included study design, 
recruitment and number of patients and control subjects, ethnicity, sex and age 
distribution, definition of diabetes and IGT and description of the ultrasound 
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method to measure carotid IMT. In case of discrepancy of assessments, consent 
was reached after discussion. The main outcome was carotid artery IMT in the 
different study groups. The analysis was restricted to studies which contained 
known numbers of participants and in which carotid artery IMT measurements 
were presented in figures. Attempts were made to obtain complementary data in 
studies lacking necessary data. 
Updated review 
In paper IV an updated meta-analysis of the difference between IMT in IGT and 
NGT was performed with the addition of the present and two new studies 
[Mohan 2006, Zhang 2006]. Adjustment for differences in age was also 
performed as age was higher in IGT than in NGT groups in seven studies[Henry 
2004, Ishizaka 2003, Keven 1999, Snehalatha 2001, Wagenknecht 1998, Zhang 
2006]. In previous studies it has been reported that an age difference of one year 
corresponds to a 0.01 mm difference in CCA IMT [Hedblad 2000, Howard 1993, 
Le Gal 2003] 
Materials and Methods 
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Paper II-IV 
Study population and study design 
DIWA study
Screening
OGTT x 2
n=2595
DM IGT NGT
n=241 n=1655
64-åriga kvinnor i Göteborg
NGT
random
Known
t2D
New 
t2D
NGT
matched
Paper II
Paper III
Paper IVn=375
 
Figure 6. Overall design of the DIWA-study;  paper II - the screening procedure;  paper 
III - atherosclerosis in t2D;  paper IV - atherosclerosis in IGT.  
 
Inclusion and exclusion criteria 
The inclusion criteria were 64-year-old woman registered at the County Register 
in Gothenburg Sweden.  Exclusion criteria for all women were recent cancer 
disease, severe mental disorder, chronic inflammatory disease or other diseases 
demanding longer use of anti-inflammatory drugs. Women with drug addictions 
or other severe illnesses were excluded. Women who could not understand 
Swedish were also excluded. For women with normal glucose tolerance (NGT) 
additional exclusion criteria were  coronary heart disease, previous stroke or 
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transient ischemic attack, intermittent claudication, treatment or need for 
treatment for hypertension or dyslipidemia.  
The study was approved by the Ethical Committee of Sahlgrenska University 
Hospital. The subjects received both written and oral information before they 
gave their consent to participate. 
Screening procedure  
All the 64-year-old women identified through the County Register in Gothenburg 
were invited to take part in a screening that took place 2001-2004 and included 
women born 1937-1940.  
In all, 4856 women were sent an invitation and reply form in which they 
accepted or did not accept participation in the screening examination. Those 2893 
who accepted completed a brief questionnaire that was enclosed. Subject who in 
this first reply letter reported diseases according to exclusion criteria were 
excluded. As a reminder to non-responders a second letter was sent. An attempt 
was made to contact a sample of these non-responders for a telephone interview 
concerning their medical conditions including diabetes. 
The screening examination included an oral glucose tolerance test (OGTT). 
Women with known diabetes treated with oral anti-diabetic drugs or insulin were 
directly included in the study and examined without preceding OGTTs, whereas 
women with diet treated diabetes and fasting blood glucose (FBG) < 7.5 mmol/l 
were examined with OGTTs. The OGTT was repeated within two weeks if 
impaired glucose tolerance (IGT) or diabetes was found.  
Glucose tolerance groups 
The women were stratified into three groups; type-2 diabetes, IGT and NGT. In 
the NGT group of 1651 women, 1231 women had no history of cardiovascular 
disease and were without medication for hypertension and hyperlipidemia. Out of 
this healthy group, two groups were recruited. The first group (NGTr) of 99 
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women was randomly selected from the entire NGT group. The second group 
(NGTm) consists of 96 women matched to the IGT group for body mass index 
(BMI) and waist-hip-ratio (WHR).  
Sample size calculations   
The preliminary sample size was calculated as the number of subjects necessary 
to include in order to show a significant difference in the common carotid artery 
(CCA) intima-media thickness (IMT) between women with type-2 diabetes and 
normal glucose tolerance (α<0.05 and β=0.20). The assumptions were based on 
data obtained from a large population-based study of 3800 women 55-67 years 
old in Malmö Sweden using almost similar ultrasound technique (personal 
communication Hedblad). These Malmö women with NGT had a mean CCA 
IMT of 0.76±0.13 mm and it was 0.04 mm higher IMT in the diabetes group. The 
calculations indicated that 200 women with type-2 diabetes and 200 with normal 
glucose tolerance would be included in the study.  
Examinations 
At both entry and at the ultrasound examination the subjects were examined with 
anthropometric measurements and blood pressure. The first visit to the 
Wallenberg Laboratory included completing of questionnaires, anthropometric 
measures, measurement of blood pressure, recording of ECG and examination 
with OGTT. The second visit, within a few weeks included the ultrasound 
examination. 
Questionnaires 
Self-administered questionnaires were used to obtain information on previous 
and present disease, current medication, smoking habits and family history of 
diabetes[CM Berg 2005]. 
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Anthropometry  
Body weight was measured in underwear on a balance scale to the nearest 0.1 kg 
and height to the nearest 1.0 cm. Waist and hip circumference were performed 
with the patient standing and in accordance with current guidelines. Waist-hip-
ratio (WHR) and body mass index (BMI) were calculated. BMI was defined as 
weight in kilograms divided by the squared height in meters.  
Blood pressure 
Blood pressure was measured in the right arm with the patient in supine position, 
using a cuff of appropriate size after at least 5 minutes of rest. The mean of two 
recordings was used.  
Oral glucose tolerance test (OGTT) 
A 75g OGTT (WHO) was performed in the morning (before 11 a.m.), fasting- 
and 2-h post load capillary blood glucose were measured. The participants had 
been asked to fast overnight, to avoid heavy physical activity during the previous 
day and to avoid smoking in the morning before the test. Women who reported a 
current infection had the examination postponed two weeks. Women fulfilling 
the criteria for DM or IGT were re-examined within 2 weeks with a repeated 
OGTT. If fasting glucose was in the diabetic range at the second examination, 
OGTT was not performed. 
Ultrasound measurements of the carotid arteries 
Examination was performed with an ultrasound scanner (Acuson Sequoia 512 
Siemens, Mountain View, CA) with a linear 8-MHz transducer aperture of 42 
mm. An electrocardiographic signal (lead II) was simultaneously recorded to 
synchronize the image capture to the top of the R wave in order to minimize 
variability during the cardiac cycle. The right and left carotid arteries were 
scanned at the level of the bifurcation. At the position of the thickest part 
(visually judged), frozen longitudinal images of the common carotid artery 
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(CCA) and the carotid bulb were recorded. A short real-time sequence was also 
recorded to assist in interpreting frozen images.  
The ultrasound images were analyzed in an automated analyzing system, based 
on automatic detection of the echo structures in the image but with the option to 
make manual corrections by the operator [Wendelhag 1997]. IMT was defined as 
the distance from the leading edge of the lumen-intima interface of the far wall to 
the leading edge of the media-adventitia interface of the far wall. The 
measurement of IMT in the carotid artery was made in two separate segments 
(Figure 7): along a 10-mm-long segment in the CCA, and along a 10-mm-long 
segment distal to the beginning of the carotid artery bulb, (i.e. where the echoes 
from the near and far walls are no longer parallel).  
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Figure 7. Ultrasound picture of carotid artery.   
 
The computer program calculated the mean thickness of the intima-media 
complex of the far wall. Lumen diameter was defined by the distance between 
the leading edges of the intima-lumen interface of the near wall and the lumen-
intima interface of the far wall. A composite measure of IMT in the carotid artery 
was calculated as the mean IMT in the CCA and the carotid bulb from the right 
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and left side. The interobserver  variability for measurement of IMT in the CCA 
and the carotid artery bulb is 5.3% and 6.0%, respectively, and 7.6 % for the 
composite measure [Schmidt 1999].   
The screening for plaques was performed over a larger area of the carotid arteries 
starting 40 mm proximally to the bulb and extending 10 mm in to internal carotid 
artery and external carotid artery, respectively. The right and left carotid arteries 
were scanned both longitudinally and transversely to assess the occurrence of 
plaques. A plaque was defined as a distinct area with an IMT >50% greater than 
neighbouring sites (visually judged). This analysis included plaques in the near 
wall as well as the far wall in both the carotid arteries. The total numbers of 
plaques were calculated. A computer program was used to calculate the area of 
each plaque and the total areas were computed. The assessment of plaque 
echogenicity was based on the version of classification proposed by Gray-Weale 
et al [Gray-Weale 1988], modified in the present study to two classes; 1) 
dominantly or substantially echolucent plaques, or 2) dominantly or uniformly 
echogenic. Two examiners simultaneously classified the plaque echogenicity, 
which has previously been shown to have good reproducibility (К=0.95) 
[Schmidt 2003]. Echogenicity was defined in each plaque and the ratio between 
the numbers of echolucent and all plaques was calculated. 
Biochemical measurements  
At the visit with ultrasound examination blood samples for biochemical analysis 
were collected and serum and plasma were frozen in aliquots at -70ºC within 4 
hours. 
Serum lipids 
The cholesterol and triglyceride levels were determined by fully enzymatic 
techniques (Thermo Clinical Labsystems, Espoo, Finland). All analyses were 
performed on a Konelab 20 autoanalyser (Thermo Clinical Labsystems) at the 
Wallenberg Laboratory. High-density lipoprotein (HDL) was determined after 
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precipitation of apolipoprotein (apo) B-containing lipoproteins with magnesium 
sulfate and dextran sulfate (Thermo Clinical Labsystems). Low-density 
lipoprotein (LDL) was calculated as described by Friedewald et al. [Friedewald 
1972]. 
HbA1c and blood glucose 
HbA1c was determined with high pressure liquid chromatography on a Mono S 
HR 5/5 column (Amersham Biosciences, Piscataway, N.J., USA and Pharmacia, 
Uppsala, Sweden) [Eckerbom 1994]. Fasting capillary blood glucose was 
measured immediately with the glucose oxidase technique by using HemoCue® 
(Hemocue AB, Ängelholm, Sweden).  
GAD-antibodies 
Antibodies against glutamic acid decarboxylase (GAD) were measured by an 
autoantibody ELISA kit (RSR Ltd, Cardiff, UK) according to WHO standard. 
Women with serum GAD antibodies ≥4.6 were defined as suffering from type 1 
diabetes[Bingley 2003]. 
Definitions  
The WHO criteria [1999] for capillary blood glucose cut-off values were used. 
IGT was defined as fasting-blood-glucose less than 6.1 mmol/l  and 2 h post 
glucose load ≥ 7.8 - < 11.1 mmol/l measured at two occasions. Diabetes was 
defined as FG ≥ 6.1 and/or 2 h post glucose load ≥ 11.1 mmol/l measured at two 
occasions. Impaired fasting glucose (IFG) was defined as fasting-blood-glucose ≥ 
5.6 - < 6.1 mmol/l and 2 h post glucose load < 7.8mmol/l. 
Subjects with normal glucose tolerance at the first OGTT were defined as normal 
glucose tolerance (NGT); women with IGT at both the first and second 
examinations were defined as IGT; women fulfilling diabetes criteria at the first 
examination but IGT at the re-examination, or the reverse were also classified as 
Materials and Methods 
29 
IGT. Women with IGT or DM at the first examination and (NGT) at the second 
examination were defined as IGT/NGT.  
Family history of diabetes was defined as having either a parent or a sibling with 
diabetes. 
Statistical analysis 
The statistical analysis was carried out using SPSS version 9.0 for Windows. 
Results are presented as means and standard deviations for continuous variables 
if nothing else is indicated, and as percentage for categorical variables. P<0.05 
(two-sided) was regarded as statistically significant. 
Paper I and IV 
For each study in the systematic review, the differences between diabetes patients 
or subjects with IGT and controls in carotid artery IMT were calculated, as well 
as the 95 % confidence intervals. A random effect model (an iterative maximum 
likelihood estimation) was used to perform the meta-analysis, resulting in an 
overall estimate of the mean difference (and 95% confidence interval) in IMT 
between diabetes patients and controls, and between patients with IGT and 
controls, respectively. Homogeneity was studied by the weighted mean µ of the 
differences ∆i between the diabetes and control group in n studies. The estimated 
standard error SEi of the difference within each group was used to calculate the 
sum of squares ∑[(∆i – µ)/ SEi]2  , which under the hypothesis of homogeneity 
has a chi-square distribution with n-1 degrees of freedom. Possible bias was also 
checked by creating a funnel plot with the difference in IMT plotted versus the 
number of subjects included in each trial. Similar analyses were performed in an 
up-dated meta-analysis after addition of the present and two new studies, and 
after adjustment for age (Paper IV). 
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Paper II 
Mann-Whitney and ANOVA were used for comparisons between groups, and a 
linear model was used for testing of trend between groups. Pearson’s correlation 
coefficient was calculated. Multiple regression was used to create an algorithm 
that was based on fasting glucose and waist girth from the first examination in 
order to predict fasting glucose at the second examination for eleven women who 
abstained from undergoing a second examination. (This was done in order to 
have the diagnoses of diabetes based on two elevated values.)  
Paper III and IV 
Unpaired Student's t-tests were used for comparison of continuous variables. In 
paper III multiple regression was used and β-coefficients are presented as 95% 
confidence intervals. Covarianse analysis was used to calculate partial correlation 
coefficients in paper IV. 
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Results 
Paper I 
(Aim: To perform a systematic review and a meta-analysis of the literature in 
order to clarify whether t2D and IGT are associated with increased carotid 
artery IMT and relate differences in IMT to clinical correlates such as age and 
risk for myocardial infarction and stroke.)  
Twenty-one studies of patients with t2D and control subjects were included in the 
review. Nine studies of subjects with IGT were identified. In all studies IMT of 
the common carotid artery was measured. Nearly all studies used the far wall for 
measurements. One study examined only the near wall[Guvener 2000]. In all 21 
studies, except one study[Tuomilehto 1998], the diabetic patients had larger IMT 
than the subjects in the control groups.  The differences were statistically 
significant in all except four studies [el-Barghouti 1997, Rajala 2002, Tuomilehto 
1998, Visona 1995](figure 7). The estimated mean difference in IMT calculated 
by a random effect model was 0.13 (95% CI: 0.123-0.144) mm. 
Three [Henry 2004, Temelkova-Kurktschiev 1999, Wagenknecht 1998] out of 
nine studies showed, with statistical significance, that carotid IMT was thicker in 
the IGT group compared with the control group (figure ). The estimated mean 
difference in IMT calculated by a random effect model was 0.04 (95% CI: 0.014-
0.071) mm. 
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Control
IMT thicker
0.0 0.1 0.2 0.3 0.4 0.5-0.1-0.2
Difference in carotid artery IMT, mm (95% CI)
Folsom WW (17) 4348   
Folsom BW 1727
Folsom WM 3490
Folsom BM 1016  
Yamasaki (18) 294
Pujia (30) 108
Geroulakos (23) 194
Visona (36) 87 
Niskanen ( 25) 182
Wei (22) 867
El-Barghouti (35) 484
Bonora (38) 114
Tuomilehto (27) 144
Wagenknecht (29) 1079
Keven (37) 41
Temel kova (31) 142
Mohan (24) 243
Taniwaki (28) 356
Guvener (21) 122
Hanefeld (33) 712
Rajala (19) 111
Ishizaka (30) 904 
Malmoe men (16) 2303
Malmoe women 3291 
Sigurdardottir (32) 271
All 22630 0.12       (0.11 to 0.13)
0.05 (0.05 to 0.05)
0.06 (0.059-0.061)
0.07 (0.069-0.071)
0.05 (0.049-0.051)
0.41 (0.404-0.416)
0.08 (0.074-0.086)
0.17 (0.165-0.175)
0.01 (-0.002-0.022)
0.14 (0.130-0.150)
0.05 (0.049-0.051)
0.02 (0.017-0.023)
0.25 (0.243-0.257)
-0.08 (-0.122- -0.038)
0.10 (0.099-0.101)
0.22 (0.200-0.240)
0.13 (0.122-0.138)
0.21 (0.204-0.216)
0.36 (0.357-0.363)
0.18 (0.171-0.189)
0.13 (0.127-0.133)
0.09 (0.076-0.104)
0.06 (0.057-0.063)
0.07 (0.069-0.071)
0.07 (0.069-0.071)
0.10 (0.096-0.104)        
Diabetes 
IMT thicker
Mean 95% CINumberStudy
Carotid Artery IMT in Diabetes vs Controls
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Figure 7. Meta-analysis showing the difference in carotid artery intima media thickness 
(IMT) between type 2 diabetes and controls (upper panel), and between patients with 
impaired glucose tolerance (IGT) and controls (lower panel). Means and 95% confidence 
intervals for the differences in separate studies and the summary of all studies are given. 
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Test for bias 
Heterogeneity was indicated as the homogeneity test rejected the null hypothesis 
for the diabetes-control groups (p<0.001). The funnel plot (figure 8) showed a 
skewed distribution with an abundance of smaller studies showing larger IMT 
differences for diabetic patients compared with control subjects. Of the 14 studies 
with fewer than 500 subjects seven[Bonora 1997, el-Barghouti 1997, Geroulakos 
1994, Niskanen 1996, Pujia 1994, Visona 1995, Yamasaki 1994] included only 
patients with well established diabetes. On the other hand just one of the 7 
studies with 500 or more subjects dealt exclusively with patient with established 
diabetes[Wei 1996]. In the present meta-analysis five studies[Ishizaka 2003, 
Keven 1999, Sigurdardottir 2004, Temelkova-Kurktschiev 1999, Wagenknecht 
1998] included only, or reported separately, newly detected diabetes patients and 
in those IMT was 0.11 (95% CI: 0.095 – 0.121) mm thicker than in control 
subjects compared to a corresponding difference of 0.13 (95% CI: 0.129 – 0.139) 
mm in the ten studies that included patients with known diabetes and control 
subjects  The approach to measure IMT in the segment with the largest thickness 
was used by nearly 50% of the authors in the studies with less than 500 subjects 
[el-Barghouti 1997, Geroulakos 1994, Mohan 2000, Niskanen 1996, Tuomilehto 
1998, Yamasaki 1994]  and by one of the larger studies[Taniwaki 1999]. The 
studies performing the IMT measurements at the thickest point showed a larger 
IMT in diabetes patients (mean difference between diabetes patients and controls 
0.21 [95% CI 0.206-0.219] mm). The corresponding mean difference in IMT, in 
studies measuring the thickness in predefined segments, was 0.09 [95% CI 0.091-
0.097] mm. The differences between t2D and controls were similar in both sexes 
and in different ethnic groups. 
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Figure 8.Funnel plot presenting difference in common carotid artery IMT between 
diabetic patients and control subjects by study size. 
 
IMT in relation to age and cardivascular risk  
In a large Swedish study [Hedblad 2000] the age-related change of carotid artery 
IMT can be estimated at 1% per year. The difference in IMT between individuals 
with type 2 diabetes patients and control subjects found in the present meta-
analysis corresponds to an expected age difference of more than 10 years, using 
these Swedish population data.    
Bots et al. [Bots 1997] used the Rotterdam population to estimate the gradient of 
risk of myocardial infarction and stroke per 1 standard deviation (0.163 mm) 
increase of IMT. They found the gradients 1.43 for myocardial infarction and 
1.41 for stroke. In the previously mentioned Swedish study, a correlation 
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coefficient of 0.77 was observed between measurements of two observers. That 
yields a coefficient of (0.77)½ between one observer and the true value. The 
gradient of risk adjusted for measurement error can be determined as 
exp(log(1.43)/r) = 1.50 for MI. The corresponding gradient for stroke was 1.48. 
The risk ratio of myocardial infarction when comparing the diabetes group versus 
controls is exp(log(1.50)⋅ 0.12 / 0.163) = 1.38, and for stroke the ratio is 1.37. 
Thus, the difference of IMT between diabetes patients and control subjects in the 
present meta- analysis is associated with increases in relative risks of 38% and 
37% for myocardial infarction and stroke, respectively. 
Paper II 
(Aim: To describe the prevalence of diabetes mellitus and IGT in a cohort of 64-
year-old women in Gothenburg and to examine the variability and practical use 
of the OGTT in the screening for IGT and diabetes.) 
The outcome of the screening process is shown in figure 9. 
Diabetes 
The prevalence of diabetes in this cohort of 64-year-old women was 9.5%. New 
diabetes mellitus, detect by screening, was found in 4.8% and known diabetes in 
4.7% of the women. Just performing fasting blood glucose measurements would 
have resulted in 44 fewer cases, i.e., 37% of new diabetes subjects who were 
identified by repeated OGTTs.  
IGT 
IGT, as defined by two OGTT, was found in 14.4% of the women. At the first 
examination, 22% of the women had IGT. At the re-examination of 367 women 
with IGT at the first examination, 175 (48%) turned out to have NGT. 
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Screening procedure
Invitation letter
n=4856
No answer
n=858 (18%)1
No
n=1105 (23%)1
Yes
n=2893 (60%)1
Excluded
n=298 (6%)1
Screened
n=2 595(53%)1
NGT
n=1651
(64%)2
IGT/NGT
n=221
(8.5%)2
IGT/-*
n=204 
(7.8%)2
IGT
n=269
(10.4%)2
new DM
n=119
(4.6%)2
DM/-†
n=9
Known DM
N=122
(4.7%) 2
IGT‡
n=375
(14.4%)2
new DM‡
n=124
(4.8%)2
 
¹) % of invited n=4856 
²) % of screened n=2595 
*) IGT at the first test, did not participate in a second test. 
†) DM value at the first test, refused to participate in the re-examination. 
‡) IGT and new DM adjusted prevalence values. 
Figure 9. The screening procedure.  
 
Characteristics by glucose tolerance status 
Table 1 shows that with worsening glucose tolerance there was a gradual increase 
in BMI, waist, waist-hip-ratio (WHR) and blood pressure, with the exception that 
known and treated diabetic women had lower blood pressure. The proportion of 
women with a family history of diabetes was doubled in the diabetic group in 
comparison with the NGT group. A closer analysis showed that women with 
IGT/IGT, in contrast to those with IGT/NGT had higher mean BMI, waist girth, 
WHR, diastolic blood pressure, heart rate and contained more subjects with 
family history of diabetes than the group with NGT women. 
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Table 1 Characteristics of 64-year-old women by glucose tolerance after two OGTT. 
 NGT IGT/NGT IGT New 
diabetes 
Known 
diabetes 
Number  1651  221  269  119  122 
Weight, kg 70.3±11.3 70.6±11.3 74.8±14.0٭ 77.5±12.7 80.0±15.2† 
Height, cm 164.5±6.0 164.3±5.6 163.6±5.8٭ 163.7±6.1 163±5.5† 
BMI 26.0±4.0 26.1±4.1 27.9±5.0٭ 28.9±4.4 30.1±5.5† 
Waist, cm 86.6±10.7 87.9±10.9 92.4±12.0٭ 96.4±11.1 101±13.5† 
Hip, cm 102.8±8.5 102.8±8.4 105.7±10.3٭ 107.1±9.6 109.3±11.8† 
WHR 0.841±0.068 0.854±0.068٭ 0.874±0.076٭ 0.900±0.068 0.924±0.072† 
Arm, cm 29.8±3.2 29.5±3.1 30.9±4.0٭ 31.2±3.8 32.4±4.3† 
Neck, cm 34.7±4.0 35.0±2.3 36.1±2.8٭ 36.7±2.5 36.9±12.8† 
Blood 
pressure 
Systolic, 
mm Hg 
146 ±20.2 149 ±18.9٭ 154 ±20.2٭ 158 ±20.7 148±21.3† 
Blood 
pressure 
Diastolic, 
mm Hg 
83 ±9.0 84.0 ±9.3 86 ±9.2٭ 89 ±9 78±10† 
Heart rate, 
beats/min 
70±9 71±10 72 ±10٭ 73 ±11 69±11† 
Family 
history 
DM 
25 % 
(379/1514) 
26 % 
(50/195) 
34 % (84/249) 
٭ 
48 % 
(53/111)  
52% (44/84)† 
Data are mean ± SD unless otherwise indicated. ٭ p<0.05 in comparison with NGT;  
† p < 0.001 for trend. NA – not applicable.  
Impaired fasting glucose (IFG) as screening test 
A fasting blood glucose FBG ≥ 5.6mmol/l (IFG) had a sensitivity of 0.87 and a 
specificity of 0.84 to identify women with diabetes. Out of 2475 women without 
known DM, 472 had FBG ≥ 5.6 mmol/l. Performing repeated OGTT in just this 
group (472 instead of 2475) would have resulted in identification of 103 new DM 
cases. Sixteen women with new DM were not identified with such an approach. 
Non-participants 
To explore the potential differences between participants and non-participants, 
attempts were made to contact the first 191 women who did not answer the two 
invitation letters. It was possible to interview 89 women by telephone contact. 
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Three of these women had known diabetes (3.4%) corresponding to 3.3% among 
the screened patients 
Paper III 
(Aim; To investigate the occurrence of echolucent plaques in diabetic patients; to 
examine if carotid artery remodelling in women is present already at the 
diagnosis of new t2D, and if it is similar to that in known t2D and to investigate if 
non-atherosclerotic remodelling may occur in t2D.)  
In total 624 women underwent the ultrasound measurements. Out of the 122 
known diabetic women; 15 had type-1 diabetes (t1D) according to the GAD-
criteria; it was not possible to examine eight women; and 99 underwent the 
ultrasound examination. For the 119 screening identified women with diabetes, 
five had t1D and eight were not examined, and 106 were included. General 
characteristics of the study group are presented in Table 2. With the exception of 
smoking and LDL cholesterol, there was a continuously worsening of the 
cardiovascular risk factor profile in parallel with impairment of glucose 
tolerance.  
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Table 2. Characteristics of a population-based cohort of 64-year-old women by 
glucose tolerance group 
Type 2 diabetes 
 
Normal glucose 
tolerance 
(n=99) 
New 
(n=106) 
Known 
(n=99) 
BMI kg/m² 24.9±3.4 28.2±4.4 30.4±5.0** 
Height, m 1.65±0.06 1.64±0.06 1.63±0.05* 
Waist circumference, cm 85.2±9.1 95.0±11.3 101.9±12.3** 
Smoking current, %(n) 15(15) 25(26) 24(23) 
Systolic blood pressure, mmHg 131±17 143±18 144±21** 
Diastolic blood pressure, mmHg 75±8 79±9 77±10* 
HbA1c,% § 4.46±0.26 5.04±0.97 6.28±1.43** 
HDL mmol/L 1.83±0.42 1.57±0.42 1.40±0.36** 
LDL mmol/L 3.70±0.97 3.45±1.0 2.95±0.99** 
Triglycerides, mmol/L § 1.12±0.59 1.35±0.73 1.84±1.1** 
Previous myocardial infarction, %(n) 0 3(3) 10(10)† 
Previous stroke, %(n) 0 2(2) 4(4) 
Hypertension known,%(n) 0 51(54) 62(61)† 
Statin therapy, %(n) 0 16(17) 39(39)† 
Fibrate therapy, %(n) 0 1(1) 5(5) 
Insulin therapy, %(n) 0 0 20(20) 
Oral anti-diabetic therapy, %(n) 0 0 57(56) 
Glitazone therapy, %(n)  0 0 10(10) 
Data are mean±SD, § geometric mean±SD. Linear trend NGT, t2Dnew, t2Dknown  
*p=0.002; **p<0.001 †No statistic test was performed as the NGT group by selection 
was free of cardiovascular diseases. 
 
It was not possible to obtain complete ultrasound examinations in 195 women. 
As shown in Table 3, these women were more obese and showed a worse 
cardiovascular risk factor profile than the women with complete examinations. 
Mean CCA IMT values were significantly higher in the women in whom 
incomplete ultrasound examinations were performed compared with the women 
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with complete examinations (incomplete: 0.89±0.20 mm, n=195; complete: 
0.84±0.16 mm; n=429; P<0.01). 
Table 3. Comparison between the women with complete ultrasound and incomplete 
ultrasound examinations. 
 Ultrasound examinations 
 Complete 
(n=429) 
Incomplete 
(n=195) 
Diabetes mellitus, %(n) 34(148) 39(76) 
Impaired glucose 
tolerance, %(n) 
31(131) 42(81)* 
BMI 26.5±4.6 28.8±4.5† 
Waist circumference, cm  89.8±11.7 96.9±12.0† 
Systolic blood pressure, 
mm Hg 
137±20 141±19† 
HDL cholesterol, mmol/L 1.64±0.44 1.44±0.40† 
Triglycerides, mmol/L 1.25±0.75 1.6±0.86† 
Geometric mean ±SD *p<0.05 †p<0.01 
IMT 
In comparison to the NGT group, women with known t2D had larger mean 
composite IMT, mean bulb IMT, and mean CCA IMT, whereas women with new 
t2D had a larger mean CCA IMT (Table 4). The mean CCA IMT was increased 
in both the known and new t2D groups, also after adjustment for the covariates 
(Table 5).  
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Table 4. Morphology of the carotid arteries. CCA- common carotid artery, IMT- 
intima media thickness. Composite IMT is the mean of IMT in CCA and carotid artery 
bulb. 
Type 2 diabetes 
 
Normal glucose 
tolerance 
(n=99) 
New 
(n=106) 
Known 
(n=99) 
Mean CCA IMT, mm  0.82±0.18 0.87±0.20**  0.91±0.18***  
Mean bulb IMT, mm  1.00±0.62 1.02±0.32 1.11±0.35**  
Mean composite IMT, mm  0.92±0.34 0.95±0.25 1.02±0.23***  
Mean lumen CCA, mm  5.80±0.60 6.08±0.58*** 6.21±0.67***  
Women with any plaque,%(n) 47(46) 46(48) 58(57)  
Women with any echolucent 
plaque %(n) 
40(39) 41(42) 57(56)* 
Mean total plaque area per 
subject mm² (mean, SD) 
11.6±19.5 15.6±26.0 
 
20.4±25.9†  
 
Mean total plaque area for 
echolucent plaques per subject, 
mm², (mean, SD) 
10.4±18.5 14.8±25.6 18.2±23.9† 
Data are geometric mean±SD, unless stated.  T-test *p<0.05, **p≤0.015; ***p<0.001 
compared to NGT group. † p<0.05 for trend 
Atherosclerotic plaques 
The proportion of women with any echolucent plaque, mean echolucent plaque 
area, and mean total plaque area increased  gradually in women with new and 
known t2D compared to the NGT group (Table 4). The ratio between the 
numbers of echolucent and total plaques did not differ between the groups (data 
not shown).  
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Figure 10. Total and echolucent plaquearea. 
 
In a stepwise multiple regression analysis, known t2D was associated with 
increased occurrence of echolucent plaques after adjustment for BMI, height, 
systolic blood pressure, smoking, and LDL cholesterol (0.20 [0.01 to 0.40 95% 
CI]) in comparison to the NGT group. For echolucent plaque area and total 
plaque area the corresponding finding was (8.4 [2.1 to 14.7 95% CI] mm2) and 
(7.4 [1.1 to 13.7 95% CI] mm²) respectively (Figure 10).  
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Table 5. Common carotid artery remodelling. Known (t2Dk, n=99) and newly 
detected (t2Dn, n=106) type 2 diabetes in comparison to healthy control women with 
normal glucose tolerance (n=99). Results are given as mean differences (95% CI) 
between t2D groups and control group. 
 Lumen diameter, 
mm 
Mean CCA IMT, 
mm 
Adjustments t2Dk t2Dn t2Dk t2Dn 
Unadjusted 0.42 
(0.24 to 0.60) 
0.28 
(0.12 to 0.44) 
0.09 
(0.04 to 0.14) 
0.06 
(0.008 to 0.12) 
Log BMI, height 0.28 
(0.06 to 0.49) 
0.22 
(0.04 to 0.40) 
0.07 
(0.004 to 0.13)
0.07 
(0.005 to 0.12) 
+ diastolic blood 
pressure,  
0.31 
(0.09 to 0.52) 
0.20 
(0.02 to 0.39) 
0.07 
(0.005 to 0.13)
0.07 
(0.006 to 0.13) 
+ serum LDL 
cholesterol 
0.17 
(-0.06 to 0.41) 
0.18 
(-0.01 to 0.36)
0.09 
(0.02 to 0.16) 
0.07 
(0.01 to 0.13) 
+ smoking 0.15 
(-0.08 to 0.37) 
0.14 
(-0.03 to 0.31)
 0.09 
(0.02 to 0.16) 
0.07 
(0.01 to 0.14) 
 
Vascular remodelling  
As shown in Table 4 and 5, both known and new t2D were associated with 
increases in mean lumen diameter in comparison to the NGT group, also after 
adjustment for BMI, height and diastolic blood pressure.  
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Table 6. Lumen and IMT in common carotid artery by tertiles of plaque area, in 
relation to subject characteristics.  
 
 
Tertiles of plaque area 
 
1 
n=78 
2 
n=42 
3 
n=58 
Plaque surface, range, mm²  No plaque 4.7 – 20.5 20.9 – 145.7 
Lumen diameter (LD), mm 6.1±0.7 6.2±0.6 6.2±0.6 
Mean CCA IMT, mm 0.83±0.140 0.92±0.16 1.01±0.23** 
Body mass index, kg/ m² 29.9±5.0 28.3±4.2 28.0±4.8* 
Systolic blood pressure, mm Hg 141±18 143±21 144±21 
Diastolic blood pressure, mm Hg 79±9 78±8 76±11** 
*p<0.05;  **p≤0.001 linear trend 
 
With an attempt to separate the impact of atherosclerotic plaques all t2D women 
were divided by tertiles of plaque area.  As shown in Table 6, tertile 3 contains 
the women with the largest plaque area and tertile 1 the women without any 
plaques. Table 6 also shows that women in tertile 2 and 3 had larger mean CCA 
IMT in comparison to tertile 1. Figure 11 demonstrates that, among women in 
tertile 3 the lumen diameter was significantly larger compared to tertile 1 also 
after adjustment for BMI and diastolic blood pressure. Similar findings were 
obtained if echolucent plaque area was used in instead of total plaque area in 
dividing the sample into tertiles (data not shown). In women without plaques, 
t2D had larger lumen diameter than NGT but the difference was not significant 
after adjustment for BMI and height (0.16 [-0.10 to 0.42, 95% CI] mm).  
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Figure 11. Differences in lumen diameter and intima-media thickness (IMT) in the 
common carotid arteries (CCA) by tertiles of carotid plaque area in 64-year-old women. 
The figure shows the differences between plaque area tertile 2, and 3, versus tertile 1 in 
which there were no plaques (plaque area=0). Means and 95% confidence intervals are 
given after adjustment for BMI and diastolic blood pressure. 
Paper IV 
(Aim: To examine if IGT, as diagnosed by doubled OGTT, is associated with 
subclinical carotid atherosclerosis assessed as IMT and occurrence of 
echolucent plaques. A post-hoc aim was to clarify if carotid IMT is thicker in 
groups of IGT compared to groups of NGT by performing an up-dated meta-
analysis adjusted for differences in age.)  
As a consequence of the study design just healthy women, free of hypertension 
and cardiovascular diseases, were recruited to the NGT groups. These healthy 
NGT women were divided into two groups; one randomly selected and the other 
matched to the IGT group for BMI and WHR. As seen in Table 7 women in the 
IGT group showed significantly higher systolic blood pressure and 
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disadvantageous changes in serum concentration of HDL-cholesterol and 
triglycerides.   
 
Table 7. Characteristics of the women by glucose tolerance group. (IGT-impaired 
glucose tolerance, NGT-normal glucose tolerance). 
 
IGT  
(n=205) 
NGTm 
(matched to 
IGT group)* 
(n=96) 
NGTr 
(randomly 
selected) 
(n=99) 
Height, cm 163±5.9 164±6.4 165±5.7† 
BMI, kg/m² 27.3±4.9 27.3±3.1 24.9±3.4‡ 
Waist circumference, cm 91.6±12.0 91.3±8.3 85.0±9.1‡ 
Smoking current, %(n) 18(37) 21(20) 15(15) 
Systolic blood pressure, mmHg 142±19 134±18† 131±17‡ 
Diastolic blood pressure, mmHg 79±9 77±9 75±8‡ 
HDL cholesterol, mmol/L 1.62±0.42 1.73±0.40¶ 1.83±0.42‡ 
LDL cholesterol, mmol/L 3.66±0.89 3.81±0.89 3.70±0.97 
Serum triglycerides, mmol/L§ 1.35±0.74 1.20±0.52¶ 1.12±0.59† 
Hypertension known, %(n) 26(53) 0 0 
Statin therapy, %(n) 10(22) 0 0 
Fibrate therapy, %(n) 0 0 0 
HRT terapi %(n) 23(48) 16(15) 30(30) 
Previous myocardial infarction %(n) 1(2) 0 0 
Previous stroke %(n) 3(6) 0 0 
*Matched to IGT for BMI and waist-hip ratio. Data are mean±SD, unless stated.  
§Geometric mean±SD. †p<0.005, ‡p<0.0005, ¶p<0.05 in comparison to IGT group. 
 
Out of the 269 women with IGT after repeated OGTTs the 212 first detected 
were invited to ultrasound measurements. It was not possible to examine seven 
women and 205 were included. In 74 women it was not possible to obtain 
complete examinations from all ultrasound locations. As shown in table 8 these 
women were more obese and showed a worse cardiovascular risk factor profile. 
They also had thicker CCA intima-media. 
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Table 8. Women with impaired glucose tolerance (IGT), with and without all 
ultrasound measurements. 
 IGT not possible to assess 
measurements from all 
locals. (n=74) 
IGT with measurements 
from all locals. (n=131) 
Weight kg 77.1±16.2 70.8±9.8* 
Waist  cm 96.4±13.0 88.9±10.5* 
BMI  29.2±5.2 26.3±4.4* 
Bp syst 145±19 140±18 
Bp dias 81±9 77±9 † 
HDL 1.52±0.41 1.67±0.42 † 
LDL 3.81±1.02 3.58±0.81 
TG 1.73±0.69 1.37±0.73* 
Mean CCA IMT  0.90±0.19 0.82±0.13* 
Max CCA  IMT  1.02±0.22 0.91±0.14* 
Heredity for DM 25% 30% 
Data are mean ± SD, t-test *p< 0.005,  †p<0.05 
IMT and plaques 
Mean CCA IMT, mean bulb IMT and mean composite IMT did not differ 
between the groups (Table 9). The NGTm and NGTr groups were combined as 
there was no difference between the groups in IMT. There was still no difference 
in mean CCA IMT between the IGT and the combined NGT-group [0.84 (95% 
CI -0.03 to 0.03) vs 0.84 (95% CI   -0.03 - 0.03) mm].  No differences in the 
results were found when statin treatment or medication for hypertension in the 
IGT group was taken into account. In the combined IGT, and NGT group CCA 
IMT correlated to systolic blood pressure (0.23, p<0.001), previous smoking 
(0.13, p=0.020), and negatively to HDL cholesterol, but not to LDL cholesterol, 
current smoking, or HbA1c (data not shown). The proportions of subjects with a 
family history of diabetes in any of the parents (FH+) were 29 % (n=59), and 
17% (n=32), in the IGT and NGT groups, respectively (p=0.006). This difference 
in proportions was statistically significant for a family history of maternal (19% 
[n=38] versus 11% [n=20], p=0.027), but not for paternal diabetes. In the 
combined IGT and NGT groups FH+ was associated with 0.03 (96% CI -0.007 to 
0.07) mm larger CCA IMT in comparison to those with no family history of 
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diabetes (FH-). Women with a family history of maternal diabetes were 
associated with a larger CCA IMT than in those with FH- (mean difference 0.05 
mm [95% CI 0.005 to 0.10 mm]). In a covariance analysis log CCA IMT was 
associated with maternal diabetes (partial correlation coefficient=0.12, p=0.027), 
independently of glucose tolerance group (IGT/NGT), systolic blood pressure, 
HDL cholesterol, and smoking. 
Atherosclerotic plaques 
As shown in Table 9 the proportion of women with any plaque, mean number of 
plaque per subject, and mean total plaque area per subject did not differ between 
the groups. The corresponding findings concerning echolucent plaques did not 
differ between the groups. The ratio between the numbers of echolucent and total 
plaques was similar between the groups (Table 9). 
Table 9. Morphology of the carotid arteries. 
(IGT-impaired glucose tolerance, NGT normal glucose tolerance, CCA common carotid 
artery). Composite IMT is the mean of IMT in CCA and carotid artery bulb. 
Geometric mean ±SD, unless stated 
٭Matched to IGT group for BMI and waist-hip-ratio 
 IGT (n=205) NGT matched to IGT group٭(n=96) 
NGT randomly 
selected (n=99) 
Mean CCA IMT, mm (n) 0.83±0.16 
(205) 
0.84±0.15 (96) 0.82±0.18 (99) 
Mean bulb IMT, mm (n) 0.99±0.30 
(181) 
0.96±0.24 (90) 1.00±0.62 (98) 
Mean composite IMT,  mm 
(n) 
0.91±0.19 
(180) 
0.91±0.16 (89) 0.92±0.34 (98) 
Women with any plaque, 
%(n) 
40(82) 38(37) 46(46) 
Mean total plaque area per 
subject mm2 (mean, SD) 
12.0±25.4 10.4±17.7 11.9±19.6 
Women with any echolucent 
plaque, %(n) 
34(67) 34(33) 40(40) 
Mean total area for 
echolucent paques per 
subject, (mean SD) 
10.6±24.8 9.0±16.6 10.2±18.5 
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Meta-analysis 
Three new studies including our own were found as an addition to the 9 
previously reviewed studies. Three out of twelve studies showed that carotid IMT 
was thicker in the IGT group compared to the normal control group after 
adjustment for age (Figure 12). The observed variability in study results was 
greater than expected to occur by chance. The estimated mean difference in IMT, 
calculated by a random effect model, was 0.03 (95% CI 0.012 to 0.048) mm 
(Figure 12). 
 
Figure 12. Meta-analysis. Studies comparing intima-media thickness (IMT) between 
groups with impaired (IGT) and normal (NGT) glucose tolerance. 
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Discussion 
The major cause of death in type 2 diabetes is macrovascular, atherosclerotic 
disease. From a clinical standpoint it is of great importance to identify 
individuals at risk for, or suffering from diabetes as correctly and as early as 
possible, and to clarify when, and how atherosclerosis starts to develop. These 
issues are addressed in this thesis in the format of a meta-analysis of the current 
literature followed by a population based cross-sectional study. In order to 
identify and quantify atherosclerosis we have used measures obtained by B-mode 
ultrasound examinations of the carotid artery. The IMT of the carotid arteries is 
since many years an established surrogate measure of atherosclerotic disease, that 
is related to future cardiovascular diseases independently of traditional risk 
factors  [Bots 1999, O'Leary 1999, Salonen 1991]. In addition, we have also 
measured the occurrence and characteristics of atherosclerotic plaques and 
studied the vascular remodelling that may occur as a consequence of 
atherosclerosis. Our working hypothesis was that there is a gradual enlargement 
of IMT and an increased occurrence of plaques, especially echolucent plaques, 
with worsening glucose tolerance, accompanied by a remodelling that might be 
visible already in subjects with IGT.  
Paper I 
Carotid artery IMT in type 2 diabetes and IGT a systematic review 
The search in the data bases for studies evaluating the difference between type-2 
diabetes, IGT and controls resulted in 23 studies. All studies following the 
inclusion criteria were included. The results obtained in the systematic review 
showed that type-2 diabetic patients had clearly significant larger carotid artery 
IMT than control subjects, on average 0.13 mm thicker. Similar results were 
obtained in men and women, and no obvious difference between ethnicities was 
found, although Caucasians were in great majority. The only study indicating that 
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controls had larger IMT than t2D was Finnish  [Tuomilehto 1998], however 
statistically non-significant, and with a wide CI. This study was performed at the 
30th year of follow-up of a cohort consisting of men with very high mortality 
from coronary heart disease.  The author speculated that the unexpected result 
could be due to selective survival of the subjects. A quality scoring between the 
included studies was not used and the different studies were not weighted 
differently. Even if the main interest was to summarise the current literature 
regarding the difference in IMT between diabetes, IGT and controls, the 
systematic review is also important as a study of heterogeneity and differences 
between studies.  
Heterogeneity 
The statistical homogeneity test indicated heterogeneity between the studies 
examining the difference in IMT between diabetic patients and controls. At a 
closer analysis it was found that the included studies differed in a number of 
aspects. 
1. Publication bias? The 14 smaller studies, with less than 500 subjects, more 
often showed larger IMT-differences for diabetic patients compared with 
control subjects than did the larger studies. This may be explained by 
publication bias, favouring positive studies, but there are also other 
explanations. 
2. Selection of study groups. One possibly source of discrepancy between the 
studies is the selection of study groups. Six out of seven of the larger studies 
[Folsom 1994, Hedblad 2000, Henry 2004, Ishizaka 2003, Wagenknecht 
1998, Wei 1996] included population-based samples, whereas this was the 
case in only five of fourteen smaller studies [Mohan 2000, Rajala 2002, 
Sigurdardottir 2004, Temelkova-Kurktschiev 1999, Tuomilehto 1998]. Fifty 
percent of the smaller studies included only patients with well-established 
diabetes compared to 14% of the larger studies. Among newly detected t2D 
IMT was 0.11 (95% CI; 0.095-0.121) mm thicker than controls, compared to 
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0.13 (95%CI; 0.129-0.139) mm in the known t2D group. However, this 
obvious statistically significant difference between the groups may not only 
be related to different durations of t2D but also to different methods to 
measure IMT by ultrasound. 
3.  Ultrasound method. Measurements of IMT made in segments of  the thickest 
walls yielded larger differences in IMT between diabetes patients and 
controls [0.21 (95% CI; 0.206-0.219) mm] than assessing mean thickness in 
predefined segments [0.09 (95% CI; 0.091-0.097) mm]. In addition, 
measurement of IMT in the thickest wall segments was performed more 
often in smaller studies with a higher proportion of known diabetes than in 
larger studies. 
4. Age.  In eight studies the DM group was older than controls (ranging 1-7 
years) but the opposite was seen in three studies (range 2-8 years). Age is a 
dominant determinant of IMT and this disparity might partly reduce the 
difference of IMT between t2D and controls. Any adjustment on behalf of 
differences in age between the groups was however not done in the meta-
analysis.  
Thus, any firm conclusions of the difference in IMT between known and newly 
detected t2D versus subjects with NGT cannot bee drawn from this review, 
showing a considerable variability in studied groups and used methods. There is 
today no consensus how to measure carotid IMT[Lorenz 2007]. We do not know 
which approach is superior in predicting future cardiovascular disease in diabetic 
patients, although attempts have been made to clarify this[Iglesias del Sol 2002]. 
Too few studies were available for reviewing differences in plaque occurrence 
and differences in subjects with impaired fasting glucose in relation to controls. 
Clinical relevance 
We have tried to estimate the clinical relevance of the difference in carotid artery 
IMT between diabetic patients and controls. We used the well-known facts that 
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carotid IMT is associated with increasing age and with future cardiovascular 
disease in order to perform such estimations [Bots 1997, Chambless 2002, 
Hedblad 2000, O'Leary 1992, O'Leary 1999]. The results showed that the 
observed difference in IMT can be interpreted as if the diabetes patients are more 
than 10 years older than the control groups, and that the relative risks of 
myocardial infarction and stroke are increased by 38%, and 37%, respectively.  
Impaired glucose tolerance (IGT) 
IGT is generally considered as a pre-diabetic state. The review showed that in 3/9 
identifed studies IMT was thicken in those with IGT compared with NGT 
controls. The summary meta-analysis showed that IGT patients had a carotid 
IMT that was overall 0.04 (95% CI; 0.01 to 0.07) mm thicker than in the control 
subjects. However, in six out of nine studies the IGT group was older than the 
control group indicating that the difference in IMT between IGT and controls 
might be smaller than calculated [Howard 1993]. This issue will be discussed 
later (see Page 64). 
Paper II   
Prevalens of diabetes mellitus and impaired glucose tolerance 64-year-
old Swedish women. Experiences of using repeated orol glucose 
tolerance tests. 
In order to study the association between glucose tolerance and subclinical 
atherosclerosis a population based cohort was examined. We chose 64-year-old 
women as we wanted to keep the age-, sex- and ethnicity factors constant. 
Another reason for this age group is the rise in diabetes incidence among women 
after the age of 60 [Rathmann 2003, Ryden 2007]. The occurrence of subclinical 
atherosclerosis is also rising [Joakimsen 1999] and there is a high relative risk of 
cardiovascular disease in this age category of diabetic women [Barrett-Connor 
1998, Niskanen 1998]. According to the calculation of study size a sample of 600 
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women with 200 in each group of of t2D, IGT and NGT were required, 
indicating a number of screened subjects of 2000-2500. 
In the present study, 2595 women were screened with OGTTs. The response rate 
was initially > 80%, but > 20% refused in the end to participate. The inclusion 
rate  was similar to that in a Danish and a German study [Glumer 2003, 
Rathmann 2003]. It is generally observed that the non-participants in studies are 
sicker than the participating study subjects. However, in the telephone interviews 
of a number of non-participating women we could not obtain any evidence that 
the non-participating women had higher prevalence of known diabetes. From 
ethical points of view the health status could not be examined among women 
refusing to participate. 
OGTT 
The results showed that repeated OGTTs seem to be needed in order to identify 
all women with diabetes according to the current WHO-definition in a middle-
aged population. Otherwise, more than one third (37%) would have remained 
unidentified if only fasting blood glucose measurements had been used. 
Furthermore, the results of the OGTT showed considerable variability as more 
than 40% of the women with a diabetic OGTT at the first examination did not 
fulfil this criterion at the second examination. In addition, more than 20% had 
IGT at the first examination, but in almost 50% of the women there was 
normalization at the second examination. This high variability, observed in the 
present study, is a well known problem with the OGTT [McDonald 1965, 
Rathmann 2005]. As regard the variability of the OGT test, the coefficient of 
variation was 12% in the present study. It may also be questioned if the 
information to the patient of an abnormal result at a first test will not lead to 
drastic changes in life style, improving the results at the second test. However, it 
is clearly shown in our study that if subjects fulfil criteria for IGT or diabetes at 
one OGTT, and then show normal glucose tolerance at a repeated test, such 
subjects differ from healthy subjects with normal glucose tolerance in several 
Discussion 
55 
characteristics typical of the metabolic syndrome, i.e. high BMI, increased waist 
girth, and blood pressure. Thus, already a lone abnormal OGTT is a clear 
indication of increased risk, although this cross-sectional study provides no 
prospective information. The variability of the OGTT is related to factors such as 
duration of fasting, degree of physical activity, smoking, and inter-current 
diseases. We tried to control for these factors and obtained no indication that the 
duration of fasting played any major role in the study. Taken together, repeated 
OGTT is of great value when diagnosing diabetes and IGT, and the results do not 
indicate that the difference between the first and second OGTT results is 
primarily explained by changes in lifestyle habits. 
Prevalence of diabetes and IGT 
To the best of our knowledge there is no previously published study of the 
prevalence of diabetes and IGT in a cohort of middle-aged women, based on 
repeated OGTTs and the current definitions of these conditions. Using this 
approach, we observed a 9.5% prevalence of diabetes in 64-year-old women, 
whereas the prevalence of IGT was 14.4%. More than 40% of the women 
showed some impairment of glucose metabolism if impaired fasting glucose was 
also included. Similar to previous studies, we found that about half of the women 
with diabetes were newly diagnosed [Glumer 2003, Rathmann 2003]. Taken 
together these studies emphasise the need for better strategies to identify subjects 
with diabetes. 
Screening method 
It has been difficult to find simple and generally applicable methods for 
screening to identify diabetes [Rathmann 2005]. The results from the present 
study in combination with experiences from previous studies indicate a screening 
strategy using FBG ≥ 5.6 mmol/l as a first identification of cases targeted for 
further examinations with OGTT [Anand 2003, de Vegt 2001].  
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Paper III 
Atherosclerotic plaques and carotid arterial remodelling in women with 
known and newly diagnosed diabetes. 
In this cross-sectional study based on the cohort of 64-year-old women with t2D, 
IGT, and NGT ultrasound examinations of both carotid arteries were performed. 
The results of such examinations are dependent on both sonographer skill and 
patient characteristics. 
Missing data 
Of the, at screening identified diabetic patients it was not possible to examine 16 
women of whom 8 had known diabetes. The non-participating diabetic women 
were more obese with higher weight, BMI, waist circumference but lower 
systolic blood pressure (data not shown). In total 626 women were examined 
with ultrasound, and in 195 women the examination was not complete. These 
women, with incomplete measurements, were more obese than those with 
complete examination, demonstrating the well-known fact that obesity is a factor 
that complicates the examination. In addition, women with incomplete ultrasound 
data had a more unfavourable risk factor profile and also a thicker mean CCA 
IMT. This has to be considered in the interpretation of data. 
Ultrasound method 
In the present study IMT was measured bilaterally in CCA, and the carotid bulb. 
Measurement of IMT in ICA was avoided due to the difficulty to obtain 
representative data. A well-validated approach was used, where the 
measurements of IMT in pre-defined segments from both CCA and the bulb were 
analyzed in an automated computerized system. This technique has been shown 
to have a low interobserver variability and a good reproducibility.[Schmidt 2003, 
Schmidt 1999]. Only the far wall is possible to examine, as previously shown by 
our group [Wendelhag 1991]. We report data on CCA and carotid bulb IMT and 
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also give the results of a composite endpoint that is the mean of CCA IMT mean 
and the bulb mean IMT. The rational is that the carotid bulb is much more a 
predilection site for atherslcerosis with an annual IMT progression of 0.02 mm 
compared to 0.01 or less for the CCA IMT [Howard 1993, Mackinnon 2004]. 
Previous studies have not succeded to show that CCA IMT is superior or inferior 
to any other IMT measure to predict future CVD[Chambless 1997, Iglesias del 
Sol 2002, O'Leary 1999]. The advantage of CCA IMT is that it is the easiest 
measure to obtain in most subjects. 
Assessment of plaque occurrence and size was done in the entire CCA and 
bifurcation with good reproducibility. The assessment of plaque echogenicity 
was based on Gray-Weale et al [Gray-Weale 1988] but modified to two classes; 
1) dominantly or substantially echolucent plaques, or 2) dominantly or uniformly 
echogenic. This classification was originally developed for large carotid plaques, 
but has also been shown to provide valuable information on plaque 
characteristics in smaller plaques [Schmidt 2005, Schmidt 2003]. 
Carotid plaques 
The occurrence and increasing size of plaques are definite measures of 
atherosclerosis. Almost 60% of the women with known t2D had plaques in their 
carotid arteries compared to 40% in those in the NGT group. Almost all plaques 
were echolucent and there was no obvious increase in the proportion of 
echolucent plaques in parallel with worsening glucose tolerans. There was a 
gradual increase in echolucent plaque area that was lowest in NGT women, 
intermediate in new t2D and highest in known t2D. Our finding, that t2D is 
associated with increased occurrence of echolucent plaques, is in line with both 
accumulated data showing that echolucent plaques are associated with increases 
risk of cardiovascular disease [Grogan 2005, Honda 2004], and the association 
between diabetes and atherosclerotic disease [Kannel 1979]. However, the 
absolute majority of all plaques were echolucent. It may be assumed that small 
and early plaques contain less of fibrous tissue and calcium causing high echo-
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density. In the Tromsö study, increasing serum HbA1c concentrations across the 
cohort were also associated with increased risk of carotid plaques [Jorgensen 
2004], but the association was only apparent with echogenic and not echolucent 
plaques. However, in that study all patients with diabetes were excluded, and 
there were also other methodological differences, such as only including plaques 
protruding into the lumen. In the present study a multivariate analysis showed 
that known t2D was associated with increased echolucent plaque area after 
adjustment for BMI, height, systolic blood pressure, smoking and LDL 
cholesterol in comparison to the NGT group. This result supports the concept that 
t2D causes atherosclerosis also by other mechanisms than those mediated by 
traditional risk factors. 
Vascular remodelling  
In comparison between groups, vascular features such as IMT and lumen 
diameter may differ by other causes than atherosclerosis. IMT is steadily 
increasing by age, and may also increase because of structural changes related to 
adaptation to wall stress and other causes [Bots 2005]. Lumen diameter is related 
to body size measured as height, body weight, BMI, and to blood pressure 
[Bonithon-Kopp 1996, Henry 2004].  
Post-mortem studies performed by Glagov et al showed that human coronary 
arteries enlarge in relation to plaque area during the early phase of 
atherosclerosis, and that the lumen area is preserved or even overcompensated 
[Glagov 1987]. A few cross-sectional and one prospective studies have 
demonstrated that plaque occurrence or diffuse atherosclerosis in the carotid 
arteries is associated with enlarged vessel diameters [Bonithon-Kopp 1996, 
Kiechl 1999, Montalcini 2007, Steinke 1994]. The same seems to hold true for 
patients with known diabetes [Henry 2004]. 
In the present study clear proofs were found of vascular remodelling that had 
already occurred in women with screening detected t2D. Hence, CCA IMT, 
assessed as circumferential area was enlarged in combination with preserved or 
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even enlarged lumen diameter, remaining after adjustment for confounders such 
as height, obesity or differences in blood pressure. Further evidence that this was 
associated with the atherosclerotic burden in the carotid artery was obtained in 
the t2D women in whom lumen diameter increased by plaque burden after 
adjustment for differences in BMI and blood pressure. However in the subgroup 
of women without atherosclerotic plaques we found no differences in carotid 
artery diameters after adjustment for body size compared to the normal control 
group, indicating that remodelling is not related to diabetes per se. An intriguing 
fact is that we related the plaque area, measured in plaques that usually occur in 
the carotid bulb, to the lumen diameter in the CCA. However, other studies have 
shown that atherosclerosis in one part of the artery tree could affect another part 
of the artery [Montalcini 2007]. 
All used measures of IMT in the carotid arteries showed that both known and 
new t2D were enlarged in comparison to women with NGT. It should however, 
be kept in mind that as a consequence of the study design the women in the NGT 
group were free of cardiovascular disease and used no medication against 
hypertension or hyperlipidemi. Women on statin treatment had increased IMT in 
the different sections of the carotid arteries compared to t2D without medication, 
thus including them in the measurements did not reduce the differences seen 
between t2D and NGTr.  
In the present study the difference between known t2D and controls was 0.09 mm 
(95% CI, 0.04 - 0.14) compared to 0.13 mm (95% CI, 0.129– 0.139) in the meta-
analysis. The corresponding results for new t2D were 0.06 mm (95% CI, 0.01 – 
0.11) and 0.11 (95% CI, 0.095 – 0.12). The confidence-intervals were, however 
overlapping between this study and the meta-analysis. The mean difference in 
reviewed studies measuring the IMT in predefined segments was 0.09 mm (95% 
CI, 0.091-0.097) even though 20% of these studies were including just new t2D. 
This difference is in harmony with our result. A former study in our group 
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between men with known t2D and controls showed a difference of 0.10mm 
[Sigurdardottir 2004]. 
Interpretation 
Type 2 diabetes diagnosed by best available methods in a population sample is 
associated with carotid plaques seemingly increasing by diabetes duration. Apart 
from confirming results from the Horn study that t2D is associated with 
preserved carotid lumen diameter at increased IMT [Henry 2004] the present 
study  also provides the new information that this has occurred already in 
subjects with very early t2D, detected by screening, and that this is related to the 
atherosclerotic burden. Complete ultrasound examinations were difficult to 
obtain in some women, who were associated with an increased occurrence of 
cardiovascular risk factors and indications of thicker IMT. It is reasonable to 
assume, that the exclusion of these women reduced the differences in 
atherosclerotic measures between women with and without diabetes.  
Paper IV 
IGT and subclinical atherosclerosis in the carotid arteries 
IGT is generally regarded as a transient metabolic state occurring during the 
disease process leading to overt diabetes [Alberti 1996]. IGT is as such also a risk 
factor for future CVD [Coutinho 1999]. By defining IGT, as we did, by using a 
doubled OGTT, IGT would be a more selected group with an even higher risk 
factor for CVD. We included two healthy NGT groups; one randomly selected 
and one matched to the IGT group for body fat and body fat distribution. The 
assessment of subclinical atherosclerosis was based on measurements of IMT in 
CCA, the carotid bulb and the means of these measures. The carotid bulb is a 
predilection site for atherosclerotic process and shows a larger annual increase in 
IMT than the CCA [Howard 1993]. We also assessed the occurrence of plaques, 
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especially echolucent plaques which are known to be associated with increased 
risk of CVD in prospective studies [Gronholdt 2002, Honda 2004].  
Missing data 
In the screening process 269 women with IGT were identified after a doubled 
OGTT. The 212 first selected were further examined with ultrasound 
measurements. In seven women it was not possible to obtain readable ultrasound 
images, resulting in 205 women completing the study. The IGT women with 
incomplete ultrasound data (n=74 out of 205) were, as expected, more obese and 
had a thicker mean CCA intima-media. 
Carotid IMT and plaque 
In our population sample, none of the ultrasound measures indicated 
atherosclerotic disease associated with IGT. Hence, there was no difference in 
IMT measured in the CCA or carotid bulbs between the IGT group and the NGT 
groups. There was neither any indication of difference in the occurrence or size 
of carotid plaques. This was an unexpected finding given the fact that the IGT 
women were characterised by a more unfavourable cardiovascular risk profile 
with higher blood pressure, higher serum triglyceride levels and HDL cholesterol 
concentrations compared to the NGT group (Table 7). Potential confounders 
were concomitant treatment with statins, antihypertensive treatment and hormone 
replacement therapy. Adjusting for these variables or excluding women on such 
treatments did not change the results. A post-hoc analyse indicated that family 
history of maternal diabetes might be a  confounder, as it was associated with an 
increase in common carotid artery IMT independently of the degree of glucose 
tolerance, and traditional cardiovascular risk factors. This observation is 
supported by results from previous studies showing that family history of 
diabetes is associated with CCA IMT enlargement in healthy subjects with 
normal glucose tolerance[Kao 2005, Pannacciulli 2003].  
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Given the original power-calculation of the entire study and the results regarding 
IMT in the IGT and NGT groups, it is obvious that the study had an insufficient 
size to identify very small differences. In order to summarise the current data a 
new meta-analysis was undertaken including the present study, recently, and 
previously published reports. 
Meta-analysis of studies measuring difference in intima-media thickness 
between IGT and normal glucose tolerance. 
Our former meta-analysis was completed with the present study and two recently 
published studies [Mohan 2006, Zhang 2006]. In 2/3 of previously published 
studies the IGT group was older than the control group, the difference ranging 
from 1-6 years. We adjusted for age, as the annual increase in CCA IMT is 
calculated to 0.01mm [Hedblad 2000, Howard 1993, Le Gal 2003]. After 
adjustment for this difference, we found that in 3 out of 12 studies IGT was 
associated with a significant increased IMT compared to NGT [Henry 2004, 
Temelkova-Kurktschiev 2000, Zhang 2006]. In the meta-analysis IMT was 
overall 0.030 (95% CI 0.012 to 0.048) mm larger in the IGT group as if there was 
a difference of three years of age. Although heterogeneity was found, no obvious 
patterns of differences in IMT between IGT and NGT groups related to the 
different ultrasound methods could be discerned. Many of the studies were not 
performed in population-based samples, but represented varying selection criteria 
[Ishizaka 2003, Keven 1999, Snehalatha 2001, Temelkova-Kurktschiev 2000, 
Zhang 2006]. The possibility of publication bias of positive results must also be 
considered.  
Interpretation 
Our conclusion is that the present study was underpowered to identify small 
differences in IMT between the IGT and NGT groups. However, combining the 
present results with data from previous studies, a meta-analysis clearly shows 
that common carotid artery is slightly larger in IGT groups than that in subjects 
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with NGT. However the atherosclerotic process does not seem to be pronounced, 
as large studies are needed to identify a minor increase in IMT. A family history 
of maternal diabetes seemed to be associated with increases in CCA IMT, 
independently of current glucose tolerance, given support to previous studies 
showing similar findings. Hence, it can be assumed that the increased risk of 
future cardiovascular disease associated with IGT is related to early sub-clinical 
atherosclerosis, and to impaired glucose tolerance as a marker of subsequent 
metabolic aberrations, including diabetes, hypertension, and dyslipidemia as 
powerful risk factors.  
Limitations 
The limitations of the present study are that only 64-year-old women were 
examined, that representativity may be questioned, and that exclusion criteria 
were used. The criteria used in the inclusion of women in the study excluded 
subjects with severe or inflammatory diseases. Hence, the results cannot be 
generalised to women with such diseases. The present study is further a cross-
sectional study and no conclusion can be drawn regarding causality. Another 
limitation is that a larger sample size seems to be needed in order to identify sub-
clinical atherosclerosis in women with IGT. 
Complete ultrasound examinations were not possible in some subjects with 
increased risk of atherosclerosis. As a result the measured differences between 
the groups with glucose tolerance impairment and controls were probably less 
than the real differences if all measurements had been complete.The ultrasound 
technique does not allow a complete characterisation of the carotid artery 
geometry. As regards vessel geometry only lumen diameter and the far wall IMT 
measurements are representative of the underlying histology, necessitating 
calculations assuming symmetric wall changes in the common carotid arteries 
[Wendelhag 1991]. This seems to be the case as it has been shown that the 
increase in intimal thickness is uniform around the circumferences in the 
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common carotid artery, in which there is an axial, symmetric blood flow [Zarins 
1983]. Another limitation is that only the carotid artery has been examined but 
measurements from this artery segment is an established surrogate measure of 
atherosclerotic disease [Salonen 1991]. 
Clinical implications 
The results from this thesis indicate a screening strategy for diabetes using FBG 
≥ 5.6 mmol/l (Fasting plasma glucose ≥6.1 mmol/l) as a first identification of 
cases targeted for further examinations with OGTT. A family history of diabetes 
among parents is important information as regards future diabetes and 
cardiovascular risk. The fact that IGT does not seem to be associated with very 
accelerated atherosclerosis, in combination with previous knowledge that life-
style modifications reduces the risk for transition to diabetes, strongly indicate 
that IGT should be identified in order to start preventive measures. Our 
observation that already screening detected t2D has established atherosclerotic 
disease underlines the importance of early detection of diabetes and the need to 
start optimal risk factor reducing treatment.   
Future perspectives 
This study is a solid platform for a prospective study in order to follow the 
development of atherosclerotic disease in relation to characteristics at baseline 
and treatment efforts during follow-up. 
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Conclusions 
Paper I. A systematic review of published studies using ultrasound to measure  
intima media thickness (IMT) in the common carotid artery (CCA) in type 2 
diabetes and controls was performed, showing that in 20 out of 21 studies 
diabetic patients had greater carotid artery IMT than the subjects in the control 
groups. The meta-analysis demonstrated that type 2 diabetes was associated with 
an increase in common carotid artery IMT, which was 0.13 mm larger in diabetes 
groups than in control groups. This difference corresponds to a 10-year increase 
in age compared with age-matched controls and is associated with a nearly 40% 
increase in cardiovascular risk. The systematic review revealed heterogeneity 
between the different studies due to differences in the selection of study groups 
and also to methodological differences in assessing ultrasound measurements. 
The method to measure carotid IMT should be better standardised.  
Paper II. The cohort of 64-year-old women in Göteborg was screened, and the 
prevalence’s of known and new diabetes and impaired glucose tolerance (IGT) at 
both oral glucose tolerance tests (OGTT)s, were 4.7, 4.8 and 14.4 % respectively 
(n=2595). Half of the women with diabetes were previously undiagnosed and 
37% of the diagnoses were based on a repeated OGTT. The degree of glucose 
tolerance impairment and the number of abnormal OGTTs were directly 
associated with occurrence of components of the metabolic syndrome. In future 
screening, impaired fasting glucose i.e. plasma-glucose ≥6.1 – 6.9 mmol/l might 
be useful in selecting subjects for further examinations with OGTT. 
Paper III. In this cohort of 64 years old Swedish women with known (n=99) and 
new type-2 diabetes (n=106) and healthy subjects with normal glucose tolerance 
(n=99), ultrasound examinations showed that both new and known type 2 
diabetes were characterised by enlarged IMT CCA compared to the women with 
normal glucose tolerance. Atherosclerotic plaques, which in general were 
echolucent, increased gradually in occurrence and size from controls, to new, and 
known type 2 diabetes. This difference remained after adjustment for 
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cardiovascular risk factors. Carotid artery plaque areas were associated with an 
increase in lumen diameter independently of blood pressure and BMI. This 
carotid vascular remodelling with enlargements in IMT and lumen diameter had 
occurred already in the women with new type 2 diabetes. The remodelling 
process occurred only in women with atherosclerotic plaques and was not 
associated to type 2 diabetes per se.  
Paper IV. In the cohort of 64-year old women, IGT, as defined by repeated 
OGTT, was not associated with increased occurrence of sub-clinical 
atherosclerosis measured as IMT or plaque occurrence or size compared to 
healthy control women with normal glucose tolerance. As the study was under-
powered to identify small differences in IMT a meta-analysis of 11 previously 
published studies, using only one OGTT for diagnosing IMT, and this study was 
performed.  In three out of 12 reviewed studies IMT was larger in IGT groups 
than in control groups. A meta-analysis of the studies indicated a difference in 
IMT of 0.03 mm between IGT and controls and heterogeneity was shown. The 
95% confidence interval of the present study (-0.03 to 0.03 mm) was within the 
confidence interval of the meta-analysis (0.012-0.048 mm), indicating that IGT is 
associated with a small increase in IMT in the CCA.  
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Populärvetenskaplig sammanfattning. 
Det moderna västerländska levnadssättet har medfört att människan rör sig allt 
mindre och konsumerar allt energirikare mat. Över hela världen sker därför en 
påtaglig ökning av övervikt och fetma med åtföljande vällevnadssjukdomar som 
hjärtkärlsjukdom och diabetes. FN har alldeles nyligen klassificerat diabetes som 
en epidemi dvs. en sjukdom som ökar mkt kraftigt och med stora hälsorisker till 
följd. Diabetes har också visat sig vara en stor riskfaktor för hjärtkärlsjukdom. 
Normalt brukar kvinnor insjukna senare än män i kärlsjukdomar men när det 
gäller diabetes utjämnas könsskillnaden och kvinnor har nästan lika stor risk som 
män att avlida i hjärt- kärlsjukdom.  
Diabetes kan diagnostiseras på två sätt, antingen som ett förhöjt fasteblodglukos 
eller som ett förhöjt värde vid ett belastningstest ”oralt glukos tolerans test” 
(OGTT). I båda fallen krävs förhöjda värden vid två olika tillfällen. De personer 
som har ett förhöjt belastningsvärde men inte når upp till diabetesgränsen 
benämns ha ”nedsatt glucos tolerans” (IGT) vilket i sig indikerar en ökad risk att 
på sikt utveckla diabetes. Vid ett OGTT får personen dricka en sockerlösning och 
efter två timmar skall blodsockret ha kommit ned till ett visst värde för att 
betecknas som normal glukostolerans.  
Hjärtkärlsjukdom beror nästan alltid på åderförkalkning (ateroskleros) som i 
allmänhet utvecklas under lång tid utan några symptom. Ateroskleros uppträder 
oftast i vissa pulsådror, t.ex. i hjärtats kranskärl eller i halspulsådern. Med hjälp 
av ultraljudet kan man mäta kärlväggens tjocklek och även se eventuell 
förtjockning i kärlväggen ”plack”. Det har visat sig att dessa mätningar kan 
förutsäga risken för framtida kärlsjukdomar som stroke och hjärtinfarkt. Man kan 
också på detta sätt få en bild över vilka riskfaktorer som bidragit till 
aterosklerosutvecklingen.  
Denna avhandling handlar om riskerna med diabetes och förstadier till diabetes 
för utvecklandet av ateroskleros.  
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I) I det första delarbetet identifieras och sammanfattas tidigare studier som 
jämfört väggtjockleken i halsartären (IMT) mellan typ 2 diabetiker, IGT och 
kontrollpersoner. Av 21 funna studier visade alla utom fyra att diabetiker hade 
tjockare kärlvägg än icke-diabetiker och den genomsnittliga skillnaden i meta-
analysen uppmättes till 0,13 mm. Vad gäller förstadiet till typ 2 diabetes (IGT) 
var skillnaden inte så tydlig. I enbart tre av nio funna studier såg man en skillnad 
som i genomsnitt uppmättes till 0,04 mm. Översätter man skillnaden som 
uppmättes mellan diabetiker och icke-diabetiker till risker för framtida 
kärlsjukdomar så betyder detta att diabetikerna hade 38 % ökad risk för 
hjärtinfarkt och 37 % ökad risk för hjärninfarkt. Då väggtjockleken ökar normalt 
med åldern kan skillnaden sägas motsvara 10 års ökad ålder till diabetikernas 
nackdel. Vi fann dock att det förelåg en större skillnad i resultaten mellan 
studierna än vad som kunde förväntas vara en slumpmässig skillnad. Denna 
skillnad mellan studierna kunde bl.a. förklaras av olika mätmetoder vid 
ultraljudsundersökningarna, olika sätt att samla in studiedeltagare och kanske 
också av att det är lättare att få ett positivt resultat publicerat. 
II) I det andra delarbetet redovisas erfarenheterna från insamlandet av den egna 
studiegruppen. I syfte att få tag på tillräckligt antal diabetiker undersöktes 2595 
kvinnor, som alla var 64 år gamla, med ett upprepat oralt glukos tolerans test 
(OGTT). Som resultat av undersökningen fann vi 10 % diabetiker varav hälften 
var nyupptäckta. Vidare hade 15 % av kvinnorna IGT efter två upprepade OGTT. 
Vi fann att de kvinnor som hade ett förhöjt glukosvärde vid enbart ett test var 
mer överviktiga med ett större bukomfång och ett högre blodtryck jämfört med 
dem som hade normala glukosvärden. Hade vi enbart mätt fasteblodglukos och 
inte använt ett OGTT hade 37 % av de nyupptäckta diabetikerna missats. OGTT 
är resurskrävande och ett sätt att välja ut de som skulle genomgå testet vore att 
enbart testa de kvinnor som i fasteblodglukos låg strax under diabetesgränsvärdet 
dvs. mellan 5.6 och 6.0 mmol/l. Hade vi tillämpat denna strategi och testat enbart 
dessa 472 kvinnor i stället för 2475 hade vi missat 16 nya diabetesfall men 
sluppit över 2000 tester.  
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III) I det tredje delarbetet mätte vi väggtjocklek, plackförekomst och diameter i 
halspulsådror hos diabetiker och friska kontroller i vårt eget material. Vi fann att 
kända diabetiker hade tjockast vägg; i genomsnitt 0.09 mm tjockare än 
kontroller. De nyupptäckta diabetikerna hamnade ungefär på halva skillnaden i 
väggtjocklek gentemot kontroller. Omkring 60 % av kända diabetiker hade 
plaque mot 40 % av kontrollerna. Vi såg också att plaqueytan var större hos de 
kända diabetikerna. Kärldiametern var dock bevarad eller kompensatoriskt 
förstorad hos diabetikerna trots att kärlväggen var tjockare och att där förelåg 
plaque. Denna kompensatoriska kärlombyggnad var tydlig även när vi tog 
hänsyn till andra faktorer som övervikt, längd och blodtryck. Kärlombyggnaden 
var tydligast hos de diabetiker som hade plaque och förklaras därigenom av 
aterosklerosutvecklingen och inte av diabetessjukdomen i sig. Diabetes bidrar till 
ateroskleros men först när aterosklerosplack har uppkommit, ser vi den 
kompensatoriska kärlombyggnaden. 
IV) I det fjärde delarbetet undersöktes IGT i jämförelse med de friska kvinnorna. 
Här sågs igen skillnad vare sig i väggtjocklek eller i plaqueförekomst. En 
uppdaterad sammanställning av alla gjorda publicerade studier med tillägg av vår 
egen genomfördes, en s.k. metaanalys. Den förnyade utökade metaanalysen som 
omfattade 12 studier och 5787 individer visade en skillnad på 0,03 mm mellan 
IGT och kontroller. Vid beräkningar framkom att vår studie hamnade inom 
konfidensintervallet (sannolikhetsintervallet) för meta-analysen.  
Sammanfattningsvis framkommer det att redan vid nyupptäckt diabetes ses 
ateroskleros i form av förtjockad kärlvägg, ökad mängd plack och därmed 
sammanhängande kärlombyggnad. Det är därför viktigt att upptäcka förstadierna 
till diabetes för att försöka förhindra uppkomsten av sjukdomen. Det är också 
viktigt att vid nyupptäckt diabetes tidigt och aktivt bekämpa höga 
blodsockernivåer, blodfetter och högt blodtryck. 
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